BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9178466)

  • 1. Protective responses in mice to vaccination with multiply administered cold-adapted influenza vaccine reassortants and wild-type viruses.
    Romanova JR; Tannock GA; Alexandrova GI
    Vaccine; 1997; 15(6-7):653-8. PubMed ID: 9178466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice.
    Romanova JR; Ermachenko TA; Alexandrova GI; Tannock GA
    Vaccine; 1994 Jan; 12(1):23-7. PubMed ID: 8303936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of a live culture of cold-adapted reassortant influenza vaccines].
    Gendon IuZ; Markushin SG; Akopova II; Koptiaeva NB; Isachenko AA; Mazurkova NA; Nechaeva EA
    Vopr Virusol; 2003; 48(2):12-7. PubMed ID: 12924092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
    Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
    Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
    Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI
    Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].
    Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].
    Desheva IuA; Smolonogina TA; Sergeeva MV; Rekstin AR; Swayne D; Klimov AI; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):31-6. PubMed ID: 19340965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice.
    Wareing MD; Watson JM; Brooks MJ; Tannock GA
    J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains.
    Wareing MD; Harrison LC; Tannock GA
    Vaccine; 2005 Jul; 23(31):4075-81. PubMed ID: 15963362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
    Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
    Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses.
    Obrosova-Serova NP; Slepushkin AN; Kendal AP; Harmon MW; Burtseva EI; Bebesheva NI; Beljaev AL; Lonskaja NI; Medvedeva TE; Egorov AY
    Vaccine; 1990 Feb; 8(1):57-60. PubMed ID: 2180233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of influenza A viruses with chimeric (type A/B) hemagglutinins.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Hatta M; Goto H; Kawaoka Y
    J Virol; 2003 Jul; 77(14):8031-8. PubMed ID: 12829842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activating effect of a germanium-organic compound on immunocompetent cells during intranasal immunization of mice with a live influenza vaccine].
    Liashenko VA; Akhmatova NK; Ambrosov IV; Matelo SK; Markushin SG; Akhmatov ÉA; Sukhno AS; Khomenkov VG
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (3):60-8. PubMed ID: 24000595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
    Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.